Cell therapy for diabetes: new data, approval, buyout; GLP-1 race in weight loss reaches new stage; FDA finally approves BioMarin’s gene therapy; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.

For many…
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks